Latest Period
n/a
Security Snapshot
bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) Institutional Ownership
CUSIP: 09076W109
13F Institutional Holders and Ownership History from Q3 2022 to Q4 2025
Institutions Reporting
Shares (Excl. Options)
Price
$0.18
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value $0.007 per share
- Symbol
- BIAF on Nasdaq
- Shares outstanding
- 28,694,438
- Price per share
- $0.18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- BIAF - bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share is tracked under CUSIP 09076W109.
- Latest finished 13F holder period is not available.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 1 to 0 between Q3 2025 and Q4 2025.
- Reported value moved from $4,228 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
09076W109
Latest holder period
n/a
13F holders
13D/G owners
1
CIK / CUSIP context first
BIAF full holder history
bioAffinity Technologies, Inc. SEC filings
bioAffinity Technologies, Inc. company facts
bioAffinity Technologies, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 09076W109:
Significant Owners of bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Crumly Richard K. | 11% | $1,446,200 | 3,213,777 | Richard K. Crumly | 07 May 2025 |
Institutional Holders of bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 0 | $0 | -$4,228 | $0.18 | 0 |
| 2025 Q3 | 25,000 | $4,228 | -$96,869 | $0.17 | 1 |
| 2025 Q2 | 362,316 | $104,049 | -$25,253 | $0.29 | 17 |
| 2025 Q1 | 512,251 | $132,483 | -$26,697 | $0.26 | 17 |
| 2024 Q4 | 535,651 | $497,418 | +$62,248 | $0.91 | 16 |
| 2024 Q3 | 467,790 | $973,004 | +$137,185 | $2.08 | 14 |
| 2024 Q2 | 399,694 | $863,338 | +$345,631 | $2.16 | 17 |
| 2024 Q1 | 239,689 | $484,422 | +$181,105 | $2.02 | 14 |
| 2023 Q4 | 156,046 | $230,527 | +$54,950 | $1.47 | 12 |
| 2023 Q3 | 119,176 | $139,690 | +$26,167 | $1.16 | 10 |
| 2023 Q2 | 96,694 | $176,951 | -$10,384 | $1.83 | 7 |
| 2023 Q1 | 102,367 | $193,473 | +$54,521 | $1.89 | 6 |
| 2022 Q4 | 83,455 | $133,528 | -$13,621 | $1.60 | 5 |
| 2022 Q3 | 66,055 | $192,000 | +$192,000 | $2.91 | 4 |